SCN5A and breast cancer: After knocking out SCN5A in MDA-MB-231 cells, the expression of SNAI1 in the cells was significantly reduced, the filamentous foot length was shortened, the number was reduced, and the invasiveness was weakened [48], and the expression level of SNAI1 in breast cancer cells overexpressing NaV1.5 increases.